The Role of Surfactant Proteins in DPPC Enrichment of Surface Films  by Veldhuizen, Edwin J.A. et al.
The Role of Surfactant Proteins in DPPC Enrichment of Surface Films
Edwin J. A. Veldhuizen,* Joseph J. Batenburg,* Lambert M. G. van Golde,* and Henk P. Haagsman*§
*Department of Biochemistry and Cell Biology, and Institute of Biomembranes, Utrecht University, 3508 TD Utrecht; and §Department of
Science of Food of Animal Origin, Utrecht University, 3508 TD, Utrecht, The Netherlands
ABSTRACT A pressure-driven captive bubble surfactometer was used to determine the role of surfactant proteins in
refinement of the surface film. The advantage of this apparatus is that surface films can be spread at the interface of an air
bubble with a different lipid/protein composition than the subphase vesicles. Using different combinations of subphase
vesicles and spread surface films a clear correlation between dipalmitoylphosphatidylcholine (DPPC) content and minimum
surface tension was observed. Spread phospholipid films containing 50% DPPC over a subphase containing 50% DPPC
vesicles did not form stable surface films with a low minimum surface tension. Addition of surfactant protein B (SP-B) to the
surface film led to a progressive decrease in minimum surface tension toward 1 mN/m upon cycling, indicating an enrichment
in DPPC. Surfactant protein C (SP-C) had no such detectable refining effect on the film. Surfactant protein A (SP-A) had a
positive effect on refinement when it was present in the subphase. However, this effect was only observed when SP-A was
combined with SP-B and incubated with subphase vesicles before addition to the air bubble containing sample chamber.
Comparison of spread films with adsorbed films indicated that refinement induced by SP-B occurs by selective removal of
non-DPPC lipids upon cycling. SP-A, combined with SP-B, induces a selective adsorption of DPPC from subphase vesicles
into the surface film. This is achieved by formation of large lipid structures which might resemble tubular myelin.
INTRODUCTION
Pulmonary surfactant is a mixture of lipids and specific
proteins that is secreted by the epithelial type II cells into
the alveolar space. Its main function is to reduce the surface
tension () at the air/liquid interface in the lung. This is
needed to lower the work of breathing and to prevent
alveolar collapse at end-expiration.
Surfactant proteins have been shown to be critical for
effective physiological function within the lung. In vitro
studies show that adsorption of lipids into an air/liquid
interface is greatly enhanced when small amounts of the
hydrophobic surfactant proteins B or C (SP-B and SP-C) are
added (Oosterlaken-Dijksterhuis et al., 1991; Pe´rez-Gil et
al., 1992; Schu¨rch et al., 1994; Krill and Gupta, 1994). The
hydrophilic surfactant protein A (SP-A) does not have this
effect by itself but seems to enhance the effect of SP-B
(Cockshutt et al., 1990). The importance of SP-B and SP-C
is also apparent from treatment of the neonatal and acute
respiratory distress syndrome. Administration of exogenous
surfactants containing SP-B or SP-C or synthetic variants
thereof shows superior results compared to that of protein-
free surfactant preparations (Revak et al., 1996; Cochrane et
al., 1996; Hawgood et al., 1996; da Costa et al., 1999; Hall
et al., 1992). Besides that, lethal respiratory distress is
caused by SP-B deficiency in humans (Nogee et al., 1994;
Tredano et al., 1999) and in SP-B knockout mice (Tokieda
et al., 1997). Surprisingly, SP-C knockout mice, which have
recently been generated, seem to have normal oxygenation
(Glasser, 1999).
Dipalmitoylphosphatidylcholine (DPPC) contributes ap-
proximately 40 to 50% to the total phospholipid pool of
pulmonary surfactant (Kahn et al., 1995; Brouwers et al.,
1998; Bernhard et al., 1997). Unsaturated phosphatidylcho-
line (PC), phosphatidylglycerol (PG), neutral lipids, and
small traces of other lipids complete the composition.
Within the lung, the surface film, which consists of these
lipid components, has to withstand high surface pressures at
low lung volumes (Schu¨rch, 1982). It is generally believed
that this is achieved by enrichment of the surface film in
DPPC. Upon compression, DPPC can pack into a gel phase
that can resist these high surface pressures (Watkins, 1968).
The exact mechanism by which this enrichment in DPPC
occurs is unknown, but there are several indications that
surfactant proteins have an active role in this process.
Two main ways by which DPPC enrichment can occur
are selective adsorption of DPPC and selective removal of
non-DPPC lipids. Indications of the existence of both mech-
anisms have been described. The evidence for selective
DPPC adsorption stems from studies in the captive bubble
surfactometer (CBS; Schu¨rch et al., 1992). In these studies,
a surface film was formed at the interface of an air bubble
by adsorption of material from the surfactant-containing
subphase. After adsorption was completed, the air bubble
required less area reduction to reach very low surface ten-
sions than could be expected from the lipid composition of
the surfactant in the subphase. This indicated that DPPC
was specifically adsorbed from the subphase to the air/
liquid interface of the bubble. Indications for the selective
removal of non-DPPC lipids stem mostly from localization
studies in spread lipid/protein films on a Wilhelmy surface
balance (von Nahmen et al., 1997b; Nag et al., 1997). Upon
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compression of such films, gel-like phases surrounded by
fluid phases developed and surfactant proteins and unsatur-
ated lipids localized in these fluid phases. When more
pressure was applied to these films, collapse occurred and
the fluid phases were squeezed out of the interface (Pastrana
et al., 1994; von Nahmen et al., 1997a).
The role of other lipid components is unclear. Several in
vitro studies have indicated that the complete set of surfac-
tant lipids has superior activity over simplified lipid mix-
tures (Wang et al., 1995; Ingenito et al., 1999). Removal of,
for example, the neutral lipids resulted in lowered surface
activity. The use of simple binary or ternary lipid mixtures
supplemented with one or more surfactant proteins can lead
to assigning specific functions to specific lipids instead of
whole groups of lipids (like the above-mentioned neutral
lipids). A nice example is a recent study, which showed that
the interaction of SP-B with the anionic phospholipid PG is
required for efficient refining of the surfactant film (Nag et
al., 1999). When PG was replaced by unsaturated PC, no
refining was observed. Other studies, with sometimes con-
tradictory results, on the role of cholesterol and palmitic
acid have been conducted (Cockshutt et al., 1991; Lema and
Enhorning, 1997; Palmblad et al., 1999; Yu and Possmayer,
1994; Palmer et al., 1997; Taneva and Keough, 1997).
The pressure-driven CBS that we use in our study has
several advantages over other model systems used to test the
activity of natural or model surfactants (Putz et al., 1994).
The CBS offers a leakproof system in which the surfactant
samples can be tested dynamically. In addition, films of
known lipid/protein composition can be spread at the inter-
face of the air bubble (Putz et al., 1998), contrary to most
systems where the films at the interface are adsorbed from
surfactant material in the subphase. Because the adsorption
mechanisms can differ for different surfactant samples, the
starting situations, using adsorbed films, are not comparable
to each other when the bubble is cycled (expanded and
compressed to resemble breathing). Finally, the composi-
tion of the lipids and proteins in the subphase can be made
different from the composition of the surface film.
In order to determine the role of the surfactant proteins
we used simple ternary and binary lipid mixtures of DPPC,
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-(1-glyc-
erol) (POPG). In most studies where simple lipid mixtures
are used, relatively high amounts of 70–80% DPPC are
incorporated in the mixture. If an enrichment of the mono-
layer in DPPC occurs, only a relatively small amount of
non-DPPC lipids has to be removed. In earlier studies using
the CBS, we observed that refinement did indeed occur and
was completed after one or two cycles (Putz et al., 1999;
Veldhuizen et al., 1999). In this study, DPPC was gradually
substituted by POPC until a limiting effect of this substitu-
tion in the surface activity of the sample was observed.
Subsequently, we determined the effect of the surfactant
proteins on refinement of the monolayer, i.e., enriching it in
DPPC. The studies suggest that SP-B, but not SP-C, has a
role in refinement of the monolayer in DPPC by the selec-
tive squeeze-out mechanism. SP-A enhances the selective
adsorption of DPPC, but only when SP-B is present. No
cooperation between SP-A and SP-C was found.
EXPERIMENTAL PROCEDURES
Materials
DPPC (1,2-dipalmitoyl-sn-glycero-3-phosphocholine), POPC, and POPG
were obtained from Avanti Polar Lipids (Alabaster, AL). HEPES was from
Life Technologies (Paisley, UK). EDTA, calcium chloride (CaCl2), chlo-
roform (CHCl3), and methanol (MeOH) were from Baker Chemicals B.V.
(Deventer, The Netherlands). Organic solvents were distilled before use.
Porcine SP-B and SP-C were isolated from lung lavage according to
standard procedures (Oosterlaken-Dijksterhuis et al., 1991). Human SP-A
was isolated from human lavage as described previously (Haagsman et al.,
1987).
Vesicle preparation
Small unilamellar vesicles were prepared as follows. Lipids from stock
solutions in CHCl3/MeOH were dried under a continuous stream of nitro-
gen at room temperature. When SP-B or SP-C were required in the
vesicles, these were added and mixed with the lipids from a stock solution
in CHCl3/MeOH. The resulting dry lipid/peptide film was rehydrated by
adding CBS buffer (see below), vortexing, and incubating at 55°C for 15
min. The multilamellar vesicles thus formed were sonicated for 2  1 min
at 55°C with a 10-s interval. The vesicles were cooled to 37°C and used
immediately. When SP-A was required in the vesicles, it was added from
a stock solution in 5 mM Tris after sonication of the vesicles. In all
experiments the same surfactant protein concentrations were used: 3 mol%
SP-C and 0.75 mol% SP-B incorporated in vesicles and 0.1 g SP-A added
to the vesicles.
Biochemical analysis
To check the purity of the surfactant proteins, protein electrophoresis was
performed by one-dimensional Tricine/sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (Scha¨gger and von Jagow, 1987). After electro-
phoresis, proteins were stained with silver stain (Bio-Rad Laboratories,
Richmond, CA). The purity of phospholipids was checked by thin layer
chromatography using CHCl3:MeOH:H2O (65:35:4, v:v:v) as mobile
phase. Concentration of phospholipid stock solutions was determined using
a phosphorus assay (Rouser et al., 1970).
Captive bubble surfactometry
The capability of the surfactant proteins to insert lipids into the air/liquid
interface and to enrich the interface layer in DPPC was determined using
a pressure-driven CBS (Putz et al., 1994). A bubble (0.5 cm2) was formed
in subphase buffer (140 mM NaCl, 10 mM HEPES, 0.5 mM EDTA, 2.5
mM CaCl2, pH 6.9) by injecting air (28.5 l) into the sample chamber at
1.0 absolute atmospheric pressure (ata) and 37°C. Two methods of surface
film formation were used: film spreading and adsorption from the
subphase.
Film spreading
Stock solutions of DPPC:POPC:POPG with or without proteins were
prepared in CHCl3:MeOH (1:1, v:v). From this stock solution, 0.05 l
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(0.25 nmol lipids) was spread at the air/water interface using a glass
syringe. This resulted in a surface tension of approximately 22 mN/m
(equilibrium surface tension). In all experiments, 3 mol% SP-C or 0.75%
SP-B was used, which corresponds to the concentration resulting in max-
imum surface activity in spread films (unpublished results). The subphase
was stirred for 30 min to enhance desorption of solvent from the surface.
Subsequently, 100 l of small unilamellar vesicles were injected into the
subphase (final concentration 1 mol PL/ml) and stirring was continued
for another 15 min. This subphase phospholipid concentration results in
maximum surface activity of spread films (unpublished results). The bub-
ble area was increased by sudden lowering of the pressure inside the
sample chamber to 0.5 ata for 10 s. This resulted in approximately a
twofold area increase (depending slightly on the final surface tension).
Subsequently, the bubble was cycled five times in 1 min between two
preset pressure values of 0.5 ata and 2.8 ata, resulting in a dynamic
compression and expansion of the air bubble. After the cycling procedure,
another 15 min adsorption time was allowed, followed by a second series
of five cycles. A video camera continuously monitored the shape of the
bubble, from which the surface tension values were calculated (Putz et al.,
1998).
Film adsorption
Small unilamellar vesicles of DPPC: POPC:POPG with or without proteins
were prepared as described and injected directly into the sample chamber.
The final concentration in the subphase was 1 mol PL/ml. The material
was allowed to adsorb to the interface of the bubble for 15 min, followed
by the same cycling and re-adsorption period described above.
All lipid samples used, vesicles and spread films, contained 20% POPG,
whereas the amount of DPPC and POPC was varied. The composition will
be referred to only by the DPPC content. For example: 50% DPPC vesicles
have a composition of DPPC:POPC:POPG (50:30:20, mol:mol:mol).
RESULTS
A clear effect of the percentage of DPPC on the min values
of protein-free spread films, on a subphase containing lipo-
somes with the same composition, was observed. In previ-
ous studies (Veldhuizen et al., 1999, 2000; Putz et al., 1998,
1999) 80% DPPC was used as the standard lipid mixture,
which results in near-zero minimum surface tensions during
cycling. However, when lowered amounts of DPPC were
present, the films caused higher minimum surface tensions,
as shown in Fig. 1. At 50% DPPC, a min of either 2 mN/m
or 20 mN/m was observed for separate experiments. No
min values in between 2 and 20 mN/m were detected. This
all-or-nothing behavior is specific for the protein-free sur-
face films and, apparently, the 50% DPPC mixture is at the
limit of the ability to create very low min. Small differences
during the experiment determine whether a very low or high
min is achieved upon compression. The increase in average
minimum surface tension upon cycling of the film should
therefore be interpreted as an increase in the number of
films that are not able to create stable films with near-zero
surface tensions. When 40% DPPC is present, near-zero
values are not reached after the first cycle in any separate
experiment.
When the concentrations of DPPC were varied, no sig-
nificant differences were observed for the maximum surface
tensions (max) of SP-B or SP-C containing surface films
(Table 1). This showed that the ability of SP-B and SP-C to
insert lipids into the surface film upon expansion of the air
bubble is not affected by the percentage of DPPC.
A clear refinement of the surface film was observed when
SP-B was present in films containing 50% DPPC. Upon the
FIGURE 1 Effect of DPPC content on the minimum surface tension
(min) of spread pure lipid films. The min of the first (white bars), third
(hatched bars), and fifth compression (black bars) are shown. The com-
position of the subphase vesicles was the same as that of the spread film.
Values shown are the averages of at least three separate experiments 
SEM.
TABLE 1 Maximum and minimum surface tensions (in mN/m) of spread films during cycling
Lipid
Composition
No protein 3% SP-C 0.75% SP-B
max min max min max min
40% DPPC
1st cycle 43.6  1.6 17.2  3.5 not done not done 21.6  0.4 13.9  4.2
5th cycle 54.5  4.4 20.2  0.4 30.2  3.9 13.0  5.8
50% DPPC
1st cycle 40.9  5.6 7.0  5.6 21.4  0.9 10.2  3.8 22.1  0.2 6.9  5.2
5th cycle 58.7  1.7 13.6  5.9 39.5  5.8 19.7  0.6 32.8  1.6 2.3  1.6
80% DPPC
1st cycle 46.5  1.1 0.8  0.1 21.9  0.4 0.5  0.1 23.5  0.7 0.6  0.1
5th cycle 50.5  2.3 1.0  0.2 31.3  2.3 0.6  0.1 31.4  0.3 0.5  0.1
Values represent the mean  SEM.
The composition of the subphase vesicles was the same as that of the spread film.
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first compression a minimum surface tension of approxi-
mately 7 mN/m was achieved which gradually decreased
toward stable films with min close to 1 mN/m (Fig. 2). This
reflects an enrichment in DPPC of the surface film at the
interface. At an even lower DPPC concentration of 40% no
refinement occurred anymore and min values of approxi-
mately 13 mN/m at every compression were observed (not
shown, but comparable to the experiment described below
where, in addition to its presence in the surface film, SP-B
was also present in the subphase vesicles [Fig. 5, open
circle]).
No refining mechanism was observed when SP-C was
present in a 50% DPPC film (Fig. 2). During cycling the
min rose from approximately 10 mN/m, which is compa-
rable to the value of SP-B in this lipid mixture at the first
compression, to 19 mN/m. This indicates a loss of material
during cycling, probably due to overcompression of the
film. When different combinations of film lipid composition
and subphase vesicles lipid composition were used, it be-
came evident that only the amount of DPPC in the film just
before the compression determines the min value of the
compressed film and not the abundance of SP-C. This is
illustrated by the following experiment (Fig. 3): an 80%
DPPC film containing SP-C was cycled with 0% DPPC
(80% POPC) vesicles in the subphase. When new lipids are
inserted into the bubble interface during the first expansion,
the 80% DPPC surface film will be diluted with POPC. The
surface area is increased almost twofold in our experimental
setup and, when SP-C is present, the surface tension does
not change much during the first expansion of the bubble.
This means that the amount of lipids at the interface is
increased twofold, and a resulting final DPPC content of 40
to 50% is expected. The first compression of the bubble led
to high min values of approximately 20 mN/m, comparable
to, or even higher than the min values in the experiment
where both the subphase and the film consisted of 50%
DPPC (Fig. 2). The dilution effect was also observed when
no protein was present in film or subphase (Fig. 3). The only
difference was that the effect was faster for SP-C-containing
films because more lipids were adsorbed from the subphase
during expansion of the bubble. That more lipids are ad-
sorbed with SP-C is obvious from the lower max values for
SP-C-containing surface films compared to protein-free
films (not shown, but comparable to the other lipid mixtures
in Table 1). When SP-B was incorporated in the film, it was
able to create a min of 4 mN/m upon the first compression
(not shown). However, the dilution effect was only coun-
teracted by SP-B in the first cycle and further cycling led to
min values of 20 mN/m. The reverse process of feeding a
film containing a low amount of DPPC with vesicles rich in
DPPC worked as well. A 50% DPPC film containing SP-C
became enriched in DPPC when 80% DPPC vesicles were
present in the subphase, leading to decreased min upon
cycling (not shown).
To investigate the role of SP-A in DPPC enrichment of
the monolayer, both adsorbed films and spread films were
used. Films adsorbed from 40% DPPC vesicles containing
both SP-A and SP-B had significantly lower minimum
surface tensions than adsorbed films from vesicles contain-
ing only SP-B (Fig. 4). The samples had comparable fast
adsorption kinetics and both films reached the equilibrium
surface tension of 22 mN/m within 1 min. Films adsorbed
from vesicles that contained only SP-A failed to reach the
equilibrium surface tension after 15 min adsorption (not
shown). Consequently, the surface activity during cycling
was low. To study the role of SP-A further, spread films
containing 40% DPPC and SP-B were cycled with subphase
vesicles containing 40% DPPC, and SP-A or SP-B or both
proteins. The results are depicted in Fig. 5. From the min
values it can be seen that only when both proteins were
present in the subphase vesicles, a DPPC enrichment is
observed upon every compression. However, the effect on
DPPC enrichment was slower compared to adsorbed films
(compare Fig. 4 and Fig. 5). When only SP-A was present
FIGURE 2 Minimum surface tensions of 50% DPPC films upon cycling.
Surface films containing 50% DPPC were spread with or without proteins.
Subphase vesicles consisted of 50% DPPC without proteins (1 mol
PL/ml). Values shown are the averages of at least three separate experi-
ments  SEM.
FIGURE 3 Minimum surface tensions of 80% DPPC films upon cycling
with 0% DPPC vesicles present in the subphase. Surface films were spread
containing 80% DPPC with or without proteins. Subphase vesicles con-
sisted of 0% DPPC (1 mol PL/ml) without proteins. Values shown are the
averages of at least three separate experiments  SEM.
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in the subphase vesicles, no significant differences were
observed in the minimum surface tension compared to SP-
B-containing subphase vesicles, but a clear negative effect
was observed on the maximum surface tensions (Fig. 5). In
additional experiments, SP-A was not added to the SP-B-
containing vesicles, but injected directly into the sample
chamber, followed 5 min later by injection of the vesicles.
In these experiments, no effect of SP-A was observed (not
shown).
Similar experiments were conducted using combinations
of SP-A and SP-C. In spread films of 50% DPPC and SP-C
higher min and max were measured during cycling when
SP-A was present in the subphase than when it was absent.
The same effect of SP-A was observed using adsorbed
films: adsorption from subphase vesicles was slower in the
presence of SP-A and inferior surface activity was observed
during cycling (not shown). This suggests that the DPPC
enriching effect of SP-A occurs only in combination with
SP-B.
DISCUSSION
In this study we tested the roles of surfactant proteins A, B,
and C in refinement of surface films. In most model systems
used to test the surface activity of surfactant proteins, a
standard lipid mixture containing 70–80% DPPC is used.
An increased surface activity due to a lowered proportion of
DPPC was observed by Holm et al. (1996), but we did not
detect such an increase. We lowered the DPPC content
down to limiting conditions leading to increased minimum
surface tensions during cycling of the air bubble. Subse-
quently, we determined to what extent the surfactant pro-
teins were capable of enriching the surface film at the
interface in DPPC.
Using spread films of 50% DPPC, it was clear that SP-B
was capable of lowering the min values to near zero during
the cycling procedure (Fig. 2). These low surface tensions
can be achieved only when the interface is completely
covered with DPPC. This implies that the decreasing min
values are correlated to enrichment in DPPC of the inter-
face. SP-C did not show this behavior at all. This is in
contradiction with some studies where a role for SP-C in
this respect was proposed (Wang et al., 1996a,b; Venkitara-
man et al., 1991; Qanbar et al., 1996), but observations
similar to ours in pulsating bubble surfactometer experi-
ments have been described as well (Yu and Possmayer,
1990). Quite remarkable is also the fact that during the
cycling procedure increasing min and max were observed
with SP-C in several lipid compositions (Table 1 and Fig.
2). One of the major roles of SP-C is thought to be the
creation of a lipid reservoir that can accommodate lipids
squeezed out of the interface during compression. These
lipids can re-enter upon the next expansion of the bubble or,
in vivo, the alveolus. This lipid reservoir formation activity
of SP-C was recently visualized using scanning force mi-
croscopy (von Nahmen et al., 1997b) on films formed on a
Wilhelmy surface balance. However, in our experimental
setup, material was quite clearly lost from the interface.
Whether this is due to the dynamic system that we used or
to the lipid composition is unclear.
Enrichment of the monolayer in DPPC can occur in two
ways: selective adsorption of DPPC or selective removal of
non-DPPC lipids. In captive bubble experiments, it has been
observed that SP-A has a positive effect on specific DPPC
adsorption (Schu¨rch et al., 1992). In those experiments
films were formed by adsorption. Low amounts of lipid
extract surfactant (containing SP-B and SP-C) were used in
the subphase as the limiting factor. When SP-A was added
to the mixture, the film required less area reduction to reach
a near-zero surface tension. This implies that less non-
DPPC lipids have to be removed from the interface upon
compression, or, in other words, that a higher amount of
FIGURE 4 Effect of SP-A on surface film refinement using adsorbed
films. Surface films were adsorbed from 40% DPPC subphase vesicles (1
mol PL/ml) and subsequently cycled. Open symbols represent min val-
ues; closed symbols represent max values. Values shown are the averages
of at least three separate experiments  SEM.
FIGURE 5 Effect of SP-A on surface film refinement using spread films.
Surface films were spread containing 40% DPPC and SP-B. Subphase
vesicles (1 mol PL/ml) consisted of 40% DPPC with SP-A and/or SP-B.
Open symbols represent min values; closed symbols represent max values.
Values shown are the averages of at least three separate experiments 
SEM.
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DPPC is already present in the interface. In our experiments
we saw a similar effect for simple lipid mixtures containing
SP-B and SP-A. The DPPC enrichment, reflected in de-
creasing min values, was faster when adsorbed films were
used than with spread films: a min of approximately 4
mN/m was reached after the second cycle in adsorbed films
(Fig. 4), whereas 6 cycles were required with spread film to
achieve this surface tension (Fig. 5). This indicates that
SP-A, combined with SP-B enhances specific DPPC ad-
sorption. In the adsorbed film specific DPPC adsorption has
to a large extent occurred during formation of the film
starting from a clean interface of the bubble. In spread films,
DPPC-specific adsorption can only occur during cycling;
hence, the effect is smaller.
The effect of SP-A seems to be specific for the combi-
nation with SP-B. When SP-C was present, a negative effect
was observed on adsorption when SP-A was added to the
vesicles. This can be explained by the fact that SP-A will
have a lipid aggregating effect on the subphase vesicles in
the calcium-containing buffer that we used (Haagsman et
al., 1991). This effect is easily detected by eye. The aggre-
gated structure of the vesicles will likely hamper surface
film formation, as has been observed before in our labora-
tory (unpublished results). A similar SP-A-induced lipid
aggregation was seen when SP-B-containing vesicles were
used and was even increased by the vesicle fusing activity
of SP-B. However, the large aggregates that were formed in
the presence of SP-B are apparently structurally different
from the ones formed in the presence of SP-C, because they
seem able to induce specific DPPC adsorption, which is
reflected in the lowered min during cycling (Fig. 4). We
suggest that in these structures DPPC-enriched domains are
formed under the influence of SP-A and SP-B, and that
these domains are then inserted into the monolayer. When
SP-A was injected into the subphase before vesicle injec-
tion, no effect was observed. The calcium-containing buffer
in the sample chamber will cause self-aggregation of SP-A.
Apparently this self-aggregation hampers the DPPC domain
formation of the subphase vesicles, and thereby the positive
effect of SP-A on the surface activity. The possible role of
SP-A in the process of DPPC domain formation is sup-
ported by several observations: SP-A specifically binds
DPPC (Kuroki and Akino, 1991) and interacts with the
boundaries between condensed and fluid regions in DPPC
monolayers (Ruano et al., 1998). Besides that, SP-A was
shown to aggregate DPPC molecules in DPPC/cholesterol
mixtures in vitro (Yu and Possmayer, 1998). Although we
have no structural data on the formed structures, they could
even have resemblance to tubular myelin, since it has been
shown that reconstitution of SP-A, SP-B, DPPC, and PG
can lead to tubular myelin formation in the presence of
calcium ions (Suzuki et al., 1989). In addition, Venkitara-
man et al. (1990) showed that SP-A combined with SP-B
counteracted the inhibitory effect of albumin and hemoglo-
bin on the surface activity of simple lipid mixtures This
effect was not observed for combinations of SP-A and
SP-C, which the authors also attributed to the formation of
the specific large aggregated lipid structures by SP-A and
SP-B.
Comparison of adsorbed films of SP-B in 40% DPPC
with spread films of the same composition (Figs. 4 and 5)
shows that comparable min values are achieved on the first
compression. This indicates, contrary to some recent captive
bubble studies (Schu¨rch et al., 1998; Nag et al., 1999), that
SP-B alone does not induce specific DPPC adsorption,
because a lower min would then be expected for adsorbed
films (as observed for SP-A/SP-B mixtures, Figs. 4 and 5).
This indicates that SP-B enriches a surface film in DPPC by
specific removal of non-DPPC lipids during cycling.
Another interesting feature is observed when limiting
amounts of 40–50% DPPC are used in surface films. Often,
either a very low min of 2 mN/m or a high min of
approximately 20 mN/m is reached upon compression of the
bubble (all-or-nothing). One of the characteristics of SP-B,
and in some experiments also SP-C, is that these proteins
can stabilize films with these minimum surface tensions
between 2 and 20 mN/m. In contrast, films that contain only
phospholipids do behave according to the all-or-nothing
principle. For example, in Fig. 3 a rising min is observed
with an average value of 13 mN/m at cycle 5. This average
value is built up from experiments where some samples
reached a min of approximately 2 mN/m, and some exper-
iments had a min of 20 mN/m. A value of 13 mN/m is, in
our experimental setup, almost never observed in a single
separate experiment with protein-free phospholipid films.
Recently an interesting finding was published by Crane
and Hall (2000). They showed that the speed of compres-
sion of the air bubble in the CBS has an effect on the
minimum surface tension that is reached. Fast compressions
of a film formed from calf surfactant in a CBS led to low
minimum surface tensions, whereas a slow compression
resulted in min values 20 mN/m. Similar results were
observed for dimyristoylphosphatidylcholine monolayers.
These findings indicate that compression rates must be
standardized and care must be taken when conclusions are
drawn from min values in CBS studies.
In summary, we used simple lipid mixtures of DPPC,
POPC, and POPG to determine the role of surfactant pro-
teins in refining a surface film. The combination of spread
films and adsorbed films enabled us to distinguish between
two mechanisms of DPPC enrichment of the surface film.
SP-B enhanced the removal of non-DPPC lipids during
cycling, whereas SP-A, when combined with SP-B in ves-
icles, stimulated the DPPC-specific adsorption. No effect in
refinement of the surface film was observed for SP-C.
This research was supported by the Netherlands Foundation for Chemical
Research (SON).
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